Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...

CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the ...

The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...

Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, as well as some blockbuster cancer ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic and Wegovy.

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.

Jan. 17, 2025 – Medicare will negotiate the prices of weight loss drugs Wegovy and Ozempic with drug companies, a move that could create big savings for seniors who take the drugs, the Biden ...

If big pharma was hoping that there would not be drug price negotiations under President Trump, they seem to have had their hopes dashed. That ...

From the first 10 drugs already negotiated under ... pharma lobby have been fighting against the negotiation program — calling it a form of “price setting” — the operational focus has ...